| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.78B | $5.45B | $5.23B | $5.12B | $4.74B | $4.53B | $4.31B | $4.16B |
| Cost of Revenue | $3.91B | $3.81B | $3.69B | $3.43B | $3.45B | $3.21B | $3.07B | $257.25M |
| Gross Profit | $1.87B | $1.64B | $1.54B | $1.69B | $1.28B | $1.32B | $1.24B | $3.90B |
| Gross Margin | 32.37% | 30.11% | 29.49% | 32.94% | 27.10% | 29.15% | 28.80% | 93.81% |
| Operating Expenses | $543.62M | $445.98M | $439.04M | $412.39M | $387.34M | $388.49M | $379.16M | $2.97B |
| Operating Income | $1.33B | $1.19B | $1.10B | $1.27B | $896.68M | $931.28M | $863.67M | $923.93M |
| Operating Margin | 22.96% | 21.92% | 21.09% | 24.89% | 18.92% | 20.57% | 20.02% | 22.23% |
| Net Income | $1.07B | $970.75M | $894.39M | $1.03B | $731.77M | $760.79M | $701.47M | $1.45B |
| Net Margin | 18.53% | 17.82% | 17.11% | 20.13% | 15.44% | 16.80% | 16.26% | 34.99% |
| EPS (Basic) | $11.99 | $10.21 | $7.55 | $7.30 | $6.90 | $6.97 | $6.22 | $12.50 |
| EBITDA | $1.45B | $1.30B | $1.19B | $1.36B | $983.39M | $1.02B | $953.75M | $915.18M |
| Stock Option Compensation Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Price To Earnings Ratio | 8.74 | 11.92 | 13.20 | 9.28 | 13.77 | 15.10 | 11.97 | 7.26 |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | $9.36B | $11.57B | $11.81B | $9.57B | $10.07B | $11.49B | $8.40B | $10.55B |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Short Term Receivables | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventories | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Property, Plant & Equipment | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Investments and Advances | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Note Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Intangible Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Assets | $29.08B | $28.05B | $25.99B | $29.77B | $29.05B | $25.98B | $23.10B | $23.47B |
| Short Term Debt Incl. Current Port. of LT Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Provision for Risks Charges | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $23.77B | $23.56B | $22.04B | $21.13B | $20.28B | $18.68B | $17.68B | $17.24B |
| Non-Equity Reserves | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Stock - Carrying Value | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Common Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Shareholders Equity | $5.31B | $4.49B | $3.95B | $8.64B | $8.77B | $7.29B | $5.42B | $6.23B |
| Accumulated Minority Interest | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $5.31B | $4.49B | $3.95B | $8.64B | $8.77B | $7.29B | $5.42B | $6.23B |
| Total Liabilities & Stockholders Equity | $29.08B | $28.05B | $25.99B | $29.77B | $29.05B | $25.98B | $23.10B | $23.47B |
| Book Value Per Share | $63.20 | $47.19 | $40.33 | $84.68 | $82.69 | $66.83 | $48.05 | $53.57 |
| Tangible Book Value Per Share | $57.36 | $42.12 | $35.41 | $79.96 | $78.52 | $62.78 | $7.41 | $15.75 |
| Full-Time Employees | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Book Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | 3.68% | 3.46% | 3.44% | 3.46% | 2.52% | 2.93% | 3.04% | 6.19% |
| Return on Equity | 20.18% | 21.64% | 22.65% | 11.93% | 8.34% | 10.43% | 12.95% | 23.33% |
| Return on Invested Capital | 257.77% | 199.70% | 199.15% | 214.97% | 287.06% | 254.70% | 3.00% | 3.88% |
| Quick Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $1.07B | $970.75M | $894.39M | $1.03B | $731.77M | $760.79M | $701.47M | $1.45B |
| Depreciation | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Funds (Non Cash) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Funds from Operations | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Extraordinary Item | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Changes in Working Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Taxes Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Operating Activities | $1.40B | $1.48B | $1.42B | $1.44B | $1.48B | $1.36B | $1.28B | $1.43B |
| Capital Expenditures | $71.05M | $49.55M | $27.93M | $38.24M | $41.76M | $42.20M | $45.09M | $20.29M |
| Net Assets From Acquisitions | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Fixed Assets and Businesses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase or Sale of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale Or Maturity of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Sources | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Investing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Dividends Paid | $85.48M | $84.12M | $80.55M | $80.04M | $78.19M | $74.19M | $71.42M | $68.83M |
| Change in Capital Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Repurchase of Common Pref Stock | $1.00B | $511.10M | $454.64M | $541.43M | $443.87M | $459.57M | $421.75M | $412.99M |
| Sale of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Proceeds from Stock Options | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance or Reduction of Debt, Net | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Reduction of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Financing Active Other Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Financing Activities Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Financing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Change in Cash | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | $1.33B | $1.43B | $1.39B | $1.40B | $1.43B | $1.32B | $1.23B | $1.41B |
| Preferred Dividends (Cash Flow) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company coverage
Globe Life Inc. delivers diverse life insurance and supplementary health coverage, alongside annuity products, targeting households in the lower-middle to middle-income brackets throughout the United States. The company's operations are structured into four key segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Its offerings encompass whole life, term life, and other life protection plans; supplemental health benefits like Medicare supplements, critical illness, and accident policies; and both single-premium and flexible-premium deferred annuities. Founded in 1979 and headquartered in McKinney, Texas, the enterprise rebranded from Torchmark Corporation to Globe Life Inc. in August 2019.
Why it moved over time
Globe Life announced a $2.5 billion share buyback authorization to repurchase up to 17.7% of outstanding shares, a sizable capital-return move that can reduce share count and boost per-share metrics.
Key fact: Board approved up to $2.5 billion buyback, allowing repurchase of up to 17.7% of shares.
defenseworld.net: Globe Life (NYSE:GL) to Repurchase $2.50 billion in Stock